Red Door Analytics

Hannah is a biostatistician with several years of experience working with register-based epidemiological data. She joined Red Door Analytics in 2022, leading the applied team, and became Director of Applied Biostatistics in August 2024.

She maintains an affiliation with the Clinical Epidemiology Division, Department of Medicine Solna at Karolinska Institutet, where she contributes to pharmacoepidemiological projects within the Chronic Inflammatory Disease Epidemiology Research Group.

Publications

38 publications featuring Hannah

Peer-reviewed papers from our full list that Hannah has co-authored. Most recent first.

2026

  1. Huss V, Bower H, Björklund M, Hellgren K, Frisell T, Delcoigne B, Di Giuseppe D, Askling J. Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs—a Swedish nationwide study. Annals of the Rheumatic Diseases 2026. View →
    Cite
    @article{huss2026,
      author  = {Huss, V. and Bower, H. and Björklund, M. and Hellgren, K. and Frisell, T. and Delcoigne, B. and Di Giuseppe, D. and Askling, J.},
      title   = {{Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs---a Swedish nationwide study}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2026},
      doi     = {10.1016/j.ard.2026.02.015}
    }
    
    TY  - JOUR
    AU  - Huss, V.
    AU  - Bower, H.
    AU  - Björklund, M.
    AU  - Hellgren, K.
    AU  - Frisell, T.
    AU  - Delcoigne, B.
    AU  - Di Giuseppe, D.
    AU  - Askling, J.
    TI  - Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs—a Swedish nationwide study
    JO  - Annals of the Rheumatic Diseases
    PY  - 2026
    DO  - 10.1016/j.ard.2026.02.015
    UR  - https://doi.org/10.1016/j.ard.2026.02.015
    ER  - 
    

2025

  1. Molander V, Bower H, Frisell T, Askling J. Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis. Annals of the Rheumatic Diseases 2025;84(5):716-725. View →
    Cite
    @article{molander2025,
      author  = {Molander, V. and Bower, H. and Frisell, T. and Askling, J.},
      title   = {{Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2025},
      volume  = {84},
      number  = {5},
      pages   = {716--725},
      doi     = {10.1016/j.ard.2025.01.020}
    }
    
    TY  - JOUR
    AU  - Molander, V.
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - Askling, J.
    TI  - Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis
    JO  - Annals of the Rheumatic Diseases
    PY  - 2025
    VL  - 84
    IS  - 5
    SP  - 716
    EP  - 725
    DO  - 10.1016/j.ard.2025.01.020
    UR  - https://doi.org/10.1016/j.ard.2025.01.020
    ER  - 
    
  2. Leontyeva Y, Landtblom AR, Hultcrantz M, Lambe M, Bower H, Lambert PC, Andersson TML. Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden. Haematologica 2025. View →
    Cite
    @article{leontyeva2025,
      author  = {Leontyeva, Y. and Landtblom, A. R. and Hultcrantz, M. and Lambe, M. and Bower, H. and Lambert, P. C. and Andersson, T. M. L.},
      title   = {{Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden}},
      journal = {Haematologica},
      year    = {2025},
      doi     = {10.3324/haematol.2024.286697}
    }
    
    TY  - JOUR
    AU  - Leontyeva, Y.
    AU  - Landtblom, A. R.
    AU  - Hultcrantz, M.
    AU  - Lambe, M.
    AU  - Bower, H.
    AU  - Lambert, P. C.
    AU  - Andersson, T. M. L.
    TI  - Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden
    JO  - Haematologica
    PY  - 2025
    DO  - 10.3324/haematol.2024.286697
    UR  - https://doi.org/10.3324/haematol.2024.286697
    ER  - 
    
  3. Eberhard A, Di Giuseppe D, Askling J, Bergman S, Bower H, Chatzidionysiou K, Forsblad‐d'Elia H, Kastbom A, Olofsson T, Frisell T, Turesson C. Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study. Arthritis & Rheumatology 2025;77(3):253-262. View →
    Cite
    @article{eberhard2025,
      author  = {Eberhard, A. and Di Giuseppe, D. and Askling, J. and Bergman, S. and Bower, H. and Chatzidionysiou, K. and Forsblad‐d'Elia, H. and Kastbom, A. and Olofsson, T. and Frisell, T. and Turesson, C.},
      title   = {{Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study}},
      journal = {Arthritis \& Rheumatology},
      year    = {2025},
      volume  = {77},
      number  = {3},
      pages   = {253--262},
      doi     = {10.1002/art.43014}
    }
    
    TY  - JOUR
    AU  - Eberhard, A.
    AU  - Di Giuseppe, D.
    AU  - Askling, J.
    AU  - Bergman, S.
    AU  - Bower, H.
    AU  - Chatzidionysiou, K.
    AU  - Forsblad‐d'Elia, H.
    AU  - Kastbom, A.
    AU  - Olofsson, T.
    AU  - Frisell, T.
    AU  - Turesson, C.
    TI  - Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study
    JO  - Arthritis & Rheumatology
    PY  - 2025
    VL  - 77
    IS  - 3
    SP  - 253
    EP  - 262
    DO  - 10.1002/art.43014
    UR  - https://doi.org/10.1002/art.43014
    ER  - 
    

2024

  1. Batyrbekova N, Bower H, Dickman PW, Szulkin R, Lambert PC, Andersson TML. Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study. Communications in Statistics-Simulation and Computation 2024;53(2):993-1006. View →
    Cite
    @article{batyrbekova2024,
      author  = {Batyrbekova, N. and Bower, H. and Dickman, P. W. and Szulkin, R. and Lambert, P. C. and Andersson, T. M. L.},
      title   = {{Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study}},
      journal = {Communications in Statistics-Simulation and Computation},
      year    = {2024},
      volume  = {53},
      number  = {2},
      pages   = {993--1006},
      doi     = {10.1080/03610918.2022.2038626}
    }
    
    TY  - JOUR
    AU  - Batyrbekova, N.
    AU  - Bower, H.
    AU  - Dickman, P. W.
    AU  - Szulkin, R.
    AU  - Lambert, P. C.
    AU  - Andersson, T. M. L.
    TI  - Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study
    JO  - Communications in Statistics-Simulation and Computation
    PY  - 2024
    VL  - 53
    IS  - 2
    SP  - 993
    EP  - 1006
    DO  - 10.1080/03610918.2022.2038626
    UR  - https://doi.org/10.1080/03610918.2022.2038626
    ER  - 
    

2023

  1. Molander V, Bower H, Askling J. Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 2023;52(2):111-7. View →
    Cite
    @article{molander2023,
      author  = {Molander, V. and Bower, H. and Askling, J.},
      title   = {{Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis}},
      journal = {Scandinavian Journal of Rheumatology},
      year    = {2023},
      volume  = {52},
      number  = {2},
      pages   = {111--7},
      doi     = {10.1080/03009742.2021.2001907}
    }
    
    TY  - JOUR
    AU  - Molander, V.
    AU  - Bower, H.
    AU  - Askling, J.
    TI  - Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis
    JO  - Scandinavian Journal of Rheumatology
    PY  - 2023
    VL  - 52
    IS  - 2
    SP  - 111
    EP  - 7
    DO  - 10.1080/03009742.2021.2001907
    UR  - https://doi.org/10.1080/03009742.2021.2001907
    ER  - 
    
  2. Salinas CA, Louder A, Polinski J, Zhang TC, Bower H, Phillips S, et al. Evaluation of VTE, MACE,and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases. Rheumatology and Therapy 2023;10(1):201-23. View →
    Cite
    @article{salinas2023,
      author  = {Salinas, C. A. and Louder, A. and Polinski, J. and Zhang, T. C. and Bower, H. and Phillips, S. and others},
      title   = {{Evaluation of VTE, MACE,and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases}},
      journal = {Rheumatology and Therapy},
      year    = {2023},
      volume  = {10},
      number  = {1},
      pages   = {201--23},
      doi     = {10.1007/s40744-022-00505-1}
    }
    
    TY  - JOUR
    AU  - Salinas, C. A.
    AU  - Louder, A.
    AU  - Polinski, J.
    AU  - Zhang, T. C.
    AU  - Bower, H.
    AU  - Phillips, S.
    TI  - Evaluation of VTE, MACE,and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases
    JO  - Rheumatology and Therapy
    PY  - 2023
    VL  - 10
    IS  - 1
    SP  - 201
    EP  - 23
    DO  - 10.1007/s40744-022-00505-1
    UR  - https://doi.org/10.1007/s40744-022-00505-1
    ER  - 
    
  3. Leontyeva Y, Lambe M, Bower H, Lambert PC, Andersson TML. Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy. BMC Medical Research Methodology 2023;23(1):291. View →
    Cite
    @article{leontyeva2023,
      author  = {Leontyeva, Y. and Lambe, M. and Bower, H. and Lambert, P. C. and Andersson, T. M. L.},
      title   = {{Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy}},
      journal = {BMC Medical Research Methodology},
      year    = {2023},
      volume  = {23},
      number  = {1},
      pages   = {291},
      doi     = {10.1186/s12874-023-02118-w}
    }
    
    TY  - JOUR
    AU  - Leontyeva, Y.
    AU  - Lambe, M.
    AU  - Bower, H.
    AU  - Lambert, P. C.
    AU  - Andersson, T. M. L.
    TI  - Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy
    JO  - BMC Medical Research Methodology
    PY  - 2023
    VL  - 23
    IS  - 1
    SP  - 291
    DO  - 10.1186/s12874-023-02118-w
    UR  - https://doi.org/10.1186/s12874-023-02118-w
    ER  - 
    
  4. Bower H, Frisell T, di Giuseppe D, Delcoigne B, Lindström U, Turesson C, et al. Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 2023;9(4):e003648. View →
    Cite
    @article{bower2023,
      author  = {Bower, H. and Frisell, T. and di Giuseppe, D. and Delcoigne, B. and Lindström, U. and Turesson, C. and others},
      title   = {{Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden}},
      journal = {RMD open},
      year    = {2023},
      volume  = {9},
      number  = {4},
      pages   = {e003648},
      doi     = {10.1136/rmdopen-2023-003648}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - di Giuseppe, D.
    AU  - Delcoigne, B.
    AU  - Lindström, U.
    AU  - Turesson, C.
    TI  - Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
    JO  - RMD open
    PY  - 2023
    VL  - 9
    IS  - 4
    SP  - e003648
    DO  - 10.1136/rmdopen-2023-003648
    UR  - https://doi.org/10.1136/rmdopen-2023-003648
    ER  - 
    
  5. Huss V, Bower H, Hellgren K, Frisell T, Askling J. Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study. Annals of the Rheumatic Diseases 2023;82(7):911-9. View →
    Cite
    @article{huss2023,
      author  = {Huss, V. and Bower, H. and Hellgren, K. and Frisell, T. and Askling, J.},
      title   = {{Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2023},
      volume  = {82},
      number  = {7},
      pages   = {911--9},
      doi     = {10.1136/ard-2022-223636}
    }
    
    TY  - JOUR
    AU  - Huss, V.
    AU  - Bower, H.
    AU  - Hellgren, K.
    AU  - Frisell, T.
    AU  - Askling, J.
    TI  - Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study
    JO  - Annals of the Rheumatic Diseases
    PY  - 2023
    VL  - 82
    IS  - 7
    SP  - 911
    EP  - 9
    DO  - 10.1136/ard-2022-223636
    UR  - https://doi.org/10.1136/ard-2022-223636
    ER  - 
    
  6. Frisell T, Bower H, Morin M, Baecklund E, Di Giuseppe D, Delcoigne B, et al. Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme. Annals of the Rheumatic Diseases 2023;82(5):601-10. View →
    Cite
    @article{frisell2023,
      author  = {Frisell, T. and Bower, H. and Morin, M. and Baecklund, E. and Di Giuseppe, D. and Delcoigne, B. and others},
      title   = {{Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2023},
      volume  = {82},
      number  = {5},
      pages   = {601--10},
      doi     = {10.1136/ard-2022-223762}
    }
    
    TY  - JOUR
    AU  - Frisell, T.
    AU  - Bower, H.
    AU  - Morin, M.
    AU  - Baecklund, E.
    AU  - Di Giuseppe, D.
    AU  - Delcoigne, B.
    TI  - Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
    JO  - Annals of the Rheumatic Diseases
    PY  - 2023
    VL  - 82
    IS  - 5
    SP  - 601
    EP  - 10
    DO  - 10.1136/ard-2022-223762
    UR  - https://doi.org/10.1136/ard-2022-223762
    ER  - 
    
  7. Molander V, Bower H, Frisell T, Delcoigne B, Di Giuseppe D, Askling J. Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2023;82(2):189-97. View →
    Cite
    @article{molander2023b,
      author  = {Molander, V. and Bower, H. and Frisell, T. and Delcoigne, B. and Di Giuseppe, D. and Askling, J.},
      title   = {{Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2023},
      volume  = {82},
      number  = {2},
      pages   = {189--97},
      doi     = {10.1136/ard-2022-223050}
    }
    
    TY  - JOUR
    AU  - Molander, V.
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - Delcoigne, B.
    AU  - Di Giuseppe, D.
    AU  - Askling, J.
    TI  - Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis
    JO  - Annals of the Rheumatic Diseases
    PY  - 2023
    VL  - 82
    IS  - 2
    SP  - 189
    EP  - 97
    DO  - 10.1136/ard-2022-223050
    UR  - https://doi.org/10.1136/ard-2022-223050
    ER  - 
    
  8. Bower H, Frisell T, di Giuseppe D, Delcoigne B, Askling J. Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis. RMD Open 2023;9(4):e003630. View →
    Cite
    @article{bower2023b,
      author  = {Bower, H. and Frisell, T. and di Giuseppe, D. and Delcoigne, B. and Askling, J.},
      title   = {{Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis}},
      journal = {RMD Open},
      year    = {2023},
      volume  = {9},
      number  = {4},
      pages   = {e003630},
      doi     = {10.1136/rmdopen-2023-003630}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - di Giuseppe, D.
    AU  - Delcoigne, B.
    AU  - Askling, J.
    TI  - Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
    JO  - RMD Open
    PY  - 2023
    VL  - 9
    IS  - 4
    SP  - e003630
    DO  - 10.1136/rmdopen-2023-003630
    UR  - https://doi.org/10.1136/rmdopen-2023-003630
    ER  - 
    

2022

  1. Bower H, Frisell T, di Giuseppe D, Delcoigne B, Alenius GM, Baecklund E et al. Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision. RMD Open 2022;8(1). View →
    Cite
    @article{bower2022,
      author  = {Bower, H. and Frisell, T. and di Giuseppe, D. and Delcoigne, B. and Alenius, G. M. and {Baecklund E et al}},
      title   = {{Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision}},
      journal = {RMD Open},
      year    = {2022},
      volume  = {8},
      number  = {1},
      doi     = {10.1136/rmdopen-2021-001987}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - di Giuseppe, D.
    AU  - Delcoigne, B.
    AU  - Alenius, G. M.
    AU  - Baecklund E et al
    TI  - Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
    JO  - RMD Open
    PY  - 2022
    VL  - 8
    IS  - 1
    DO  - 10.1136/rmdopen-2021-001987
    UR  - https://doi.org/10.1136/rmdopen-2021-001987
    ER  - 
    
  2. Bower H, Frisell T, Di Giuseppe D, Delcoigne B, Askling J. Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19? Annals of the Rheumatic Diseases 2022;81(3):433-9. View →
    Cite
    @article{bower2022b,
      author  = {Bower, H. and Frisell, T. and Di Giuseppe, D. and Delcoigne, B. and Askling, J.},
      title   = {{Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2022},
      volume  = {81},
      number  = {3},
      pages   = {433--9},
      doi     = {10.1136/annrheumdis-2021-221461}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - Di Giuseppe, D.
    AU  - Delcoigne, B.
    AU  - Askling, J.
    TI  - Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
    JO  - Annals of the Rheumatic Diseases
    PY  - 2022
    VL  - 81
    IS  - 3
    SP  - 433
    EP  - 9
    DO  - 10.1136/annrheumdis-2021-221461
    UR  - https://doi.org/10.1136/annrheumdis-2021-221461
    ER  - 
    
  3. Huss V, Bower H, Wadström H, Frisell T, Askling J. Short-and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice. Rheumatology 2022;61(5):1810-8. View →
    Cite
    @article{huss2022,
      author  = {Huss, V. and Bower, H. and Wadström, H. and Frisell, T. and Askling, J.},
      title   = {{Short-and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice}},
      journal = {Rheumatology},
      year    = {2022},
      volume  = {61},
      number  = {5},
      pages   = {1810--8},
      doi     = {10.1093/rheumatology/keab570}
    }
    
    TY  - JOUR
    AU  - Huss, V.
    AU  - Bower, H.
    AU  - Wadström, H.
    AU  - Frisell, T.
    AU  - Askling, J.
    TI  - Short-and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice
    JO  - Rheumatology
    PY  - 2022
    VL  - 61
    IS  - 5
    SP  - 1810
    EP  - 8
    DO  - 10.1093/rheumatology/keab570
    UR  - https://doi.org/10.1093/rheumatology/keab570
    ER  - 
    
  4. Leontyeva Y, Bower H, Gauffin O, Lambert PC, Andersson TML. Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy. BMC Medical Research Methodology 2022;22(1):130. View →
    Cite
    @article{leontyeva2022,
      author  = {Leontyeva, Y. and Bower, H. and Gauffin, O. and Lambert, P. C. and Andersson, T. M. L.},
      title   = {{Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy}},
      journal = {BMC Medical Research Methodology},
      year    = {2022},
      volume  = {22},
      number  = {1},
      pages   = {130},
      doi     = {10.1186/s12874-022-01597-7}
    }
    
    TY  - JOUR
    AU  - Leontyeva, Y.
    AU  - Bower, H.
    AU  - Gauffin, O.
    AU  - Lambert, P. C.
    AU  - Andersson, T. M. L.
    TI  - Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy
    JO  - BMC Medical Research Methodology
    PY  - 2022
    VL  - 22
    IS  - 1
    SP  - 130
    DO  - 10.1186/s12874-022-01597-7
    UR  - https://doi.org/10.1186/s12874-022-01597-7
    ER  - 
    
  5. Di Giuseppe D, Lindstrom U, Bower H, Delcoigne B, Frisell T, Chatzidionysiou K, et al. Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden. Rheumatology 2022;61(9):3596-605. View →
    Cite
    @article{digiuseppe2022,
      author  = {Di Giuseppe, D. and Lindstrom, U. and Bower, H. and Delcoigne, B. and Frisell, T. and Chatzidionysiou, K. and others},
      title   = {{Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden}},
      journal = {Rheumatology},
      year    = {2022},
      volume  = {61},
      number  = {9},
      pages   = {3596--605},
      doi     = {10.1093/rheumatology/keab933}
    }
    
    TY  - JOUR
    AU  - Di Giuseppe, D.
    AU  - Lindstrom, U.
    AU  - Bower, H.
    AU  - Delcoigne, B.
    AU  - Frisell, T.
    AU  - Chatzidionysiou, K.
    TI  - Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden
    JO  - Rheumatology
    PY  - 2022
    VL  - 61
    IS  - 9
    SP  - 3596
    EP  - 605
    DO  - 10.1093/rheumatology/keab933
    UR  - https://doi.org/10.1093/rheumatology/keab933
    ER  - 
    
  6. Batyrbekova N, Bower H, Dickman PW, Ravn Landtblom A, Hultcrantz M, Szulkin R, et al. Modelling multiple time-scales with flexible parametric survival models. BMC Medical Research Methodology 2022;22(1):290. View →
    Cite
    @article{batyrbekova2022,
      author  = {Batyrbekova, N. and Bower, H. and Dickman, P. W. and Ravn Landtblom, A. and Hultcrantz, M. and Szulkin, R. and others},
      title   = {{Modelling multiple time-scales with flexible parametric survival models}},
      journal = {BMC Medical Research Methodology},
      year    = {2022},
      volume  = {22},
      number  = {1},
      pages   = {290},
      doi     = {10.21203/rs.3.rs-1268869/v1}
    }
    
    TY  - JOUR
    AU  - Batyrbekova, N.
    AU  - Bower, H.
    AU  - Dickman, P. W.
    AU  - Ravn Landtblom, A.
    AU  - Hultcrantz, M.
    AU  - Szulkin, R.
    TI  - Modelling multiple time-scales with flexible parametric survival models
    JO  - BMC Medical Research Methodology
    PY  - 2022
    VL  - 22
    IS  - 1
    SP  - 290
    DO  - 10.21203/rs.3.rs-1268869/v1
    UR  - https://doi.org/10.21203/rs.3.rs-1268869/v1
    ER  - 
    
  7. Bower H, Andersson TML, Crowther MJ, Lambert PC. Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt. The Stata Journal 2022;22(3):679-701. View →
    Cite
    @article{bower2022c,
      author  = {Bower, H. and Andersson, T. M. L. and Crowther, M. J. and Lambert, P. C.},
      title   = {{Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt}},
      journal = {The Stata Journal},
      year    = {2022},
      volume  = {22},
      number  = {3},
      pages   = {679--701},
      doi     = {10.1177/1536867x221124552}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Andersson, T. M. L.
    AU  - Crowther, M. J.
    AU  - Lambert, P. C.
    TI  - Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt
    JO  - The Stata Journal
    PY  - 2022
    VL  - 22
    IS  - 3
    SP  - 679
    EP  - 701
    DO  - 10.1177/1536867x221124552
    UR  - https://doi.org/10.1177/1536867x221124552
    ER  - 
    
  8. Longinetti E, Bower H, McKay KA, Englund S, Burman J, Fink K, et al. COVID-19 clinical outcomes and DMT of MS patients and population-based controls. Annals of Clinical and Translational Neurology 2022;9(9):1449-58. View →
    Cite
    @article{longinetti2022,
      author  = {Longinetti, E. and Bower, H. and McKay, K. A. and Englund, S. and Burman, J. and Fink, K. and others},
      title   = {{COVID-19 clinical outcomes and DMT of MS patients and population-based controls}},
      journal = {Annals of Clinical and Translational Neurology},
      year    = {2022},
      volume  = {9},
      number  = {9},
      pages   = {1449--58},
      doi     = {10.1002/acn3.51646}
    }
    
    TY  - JOUR
    AU  - Longinetti, E.
    AU  - Bower, H.
    AU  - McKay, K. A.
    AU  - Englund, S.
    AU  - Burman, J.
    AU  - Fink, K.
    TI  - COVID-19 clinical outcomes and DMT of MS patients and population-based controls
    JO  - Annals of Clinical and Translational Neurology
    PY  - 2022
    VL  - 9
    IS  - 9
    SP  - 1449
    EP  - 58
    DO  - 10.1002/acn3.51646
    UR  - https://doi.org/10.1002/acn3.51646
    ER  - 
    

2021

  1. Bower H, Frisell T, Di Giuseppe D, Delcoigne B, Ahlenius GM, Baecklund E, et al. Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study. Annals of the Rheumatic Diseases 2021;80(8):1086-93. View →
    Cite
    @article{bower2021,
      author  = {Bower, H. and Frisell, T. and Di Giuseppe, D. and Delcoigne, B. and Ahlenius, G. M. and Baecklund, E. and others},
      title   = {{Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2021},
      volume  = {80},
      number  = {8},
      pages   = {1086--93},
      doi     = {10.1136/annrheumdis-2021-219845}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - Di Giuseppe, D.
    AU  - Delcoigne, B.
    AU  - Ahlenius, G. M.
    AU  - Baecklund, E.
    TI  - Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
    JO  - Annals of the Rheumatic Diseases
    PY  - 2021
    VL  - 80
    IS  - 8
    SP  - 1086
    EP  - 93
    DO  - 10.1136/annrheumdis-2021-219845
    UR  - https://doi.org/10.1136/annrheumdis-2021-219845
    ER  - 
    
  2. Molander V, Bower H, Frisell T, Askling J. Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Annals of the Rheumatic Diseases 2021;80(2):169-75. View →
    Cite
    @article{molander2021,
      author  = {Molander, V. and Bower, H. and Frisell, T. and Askling, J.},
      title   = {{Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden}},
      journal = {Annals of the Rheumatic Diseases},
      year    = {2021},
      volume  = {80},
      number  = {2},
      pages   = {169--75},
      doi     = {10.1136/annrheumdis-2020-218419}
    }
    
    TY  - JOUR
    AU  - Molander, V.
    AU  - Bower, H.
    AU  - Frisell, T.
    AU  - Askling, J.
    TI  - Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
    JO  - Annals of the Rheumatic Diseases
    PY  - 2021
    VL  - 80
    IS  - 2
    SP  - 169
    EP  - 75
    DO  - 10.1136/annrheumdis-2020-218419
    UR  - https://doi.org/10.1136/annrheumdis-2020-218419
    ER  - 
    
  3. Bai G, Szwajda A, Wang Y, Li X, Bower H, Karlsson IK, Johansson B, Dahl Aslan AK, Pedersen NL, Hägg S, Jylhävä J. Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?. Age and Ageing 2021;50(6):2174-2182. View →
    Cite
    @article{bai2021,
      author  = {Bai, G. and Szwajda, A. and Wang, Y. and Li, X. and Bower, H. and Karlsson, I. K. and Johansson, B. and Dahl Aslan, A. K. and Pedersen, N. L. and Hägg, S. and Jylhävä, J.},
      title   = {{Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?}},
      journal = {Age and Ageing},
      year    = {2021},
      volume  = {50},
      number  = {6},
      pages   = {2174--2182},
      doi     = {10.1093/ageing/afab106}
    }
    
    TY  - JOUR
    AU  - Bai, G.
    AU  - Szwajda, A.
    AU  - Wang, Y.
    AU  - Li, X.
    AU  - Bower, H.
    AU  - Karlsson, I. K.
    AU  - Johansson, B.
    AU  - Dahl Aslan, A. K.
    AU  - Pedersen, N. L.
    AU  - Hägg, S.
    AU  - Jylhävä, J.
    TI  - Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?
    JO  - Age and Ageing
    PY  - 2021
    VL  - 50
    IS  - 6
    SP  - 2174
    EP  - 2182
    DO  - 10.1093/ageing/afab106
    UR  - https://doi.org/10.1093/ageing/afab106
    ER  - 
    

2020

  1. Osvald EC, Bower H, Lundholm C, Larsson H, Brew BK, Almqvist C. Asthma and all-cause mortality in children and young adults: a population-based study. Thorax 2020;75(12):1040-6. View →
    Cite
    @article{osvald2020,
      author  = {Osvald, E. C. and Bower, H. and Lundholm, C. and Larsson, H. and Brew, B. K. and Almqvist, C.},
      title   = {{Asthma and all-cause mortality in children and young adults: a population-based study}},
      journal = {Thorax},
      year    = {2020},
      volume  = {75},
      number  = {12},
      pages   = {1040--6},
      doi     = {10.1136/thoraxjnl-2020-214655}
    }
    
    TY  - JOUR
    AU  - Osvald, E. C.
    AU  - Bower, H.
    AU  - Lundholm, C.
    AU  - Larsson, H.
    AU  - Brew, B. K.
    AU  - Almqvist, C.
    TI  - Asthma and all-cause mortality in children and young adults: a population-based study
    JO  - Thorax
    PY  - 2020
    VL  - 75
    IS  - 12
    SP  - 1040
    EP  - 6
    DO  - 10.1136/thoraxjnl-2020-214655
    UR  - https://doi.org/10.1136/thoraxjnl-2020-214655
    ER  - 
    
  2. Evans M, Bower H, Cockburn E, Jacobson SH, Barany P, Carrero JJ. Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis. Clinical Kidney Journal 2020;13(5):821-7. View →
    Cite
    @article{evans2020,
      author  = {Evans, M. and Bower, H. and Cockburn, E. and Jacobson, S. H. and Barany, P. and Carrero, J. J.},
      title   = {{Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis}},
      journal = {Clinical Kidney Journal},
      year    = {2020},
      volume  = {13},
      number  = {5},
      pages   = {821--7},
      doi     = {10.1093/ckj/sfaa054}
    }
    
    TY  - JOUR
    AU  - Evans, M.
    AU  - Bower, H.
    AU  - Cockburn, E.
    AU  - Jacobson, S. H.
    AU  - Barany, P.
    AU  - Carrero, J. J.
    TI  - Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
    JO  - Clinical Kidney Journal
    PY  - 2020
    VL  - 13
    IS  - 5
    SP  - 821
    EP  - 7
    DO  - 10.1093/ckj/sfaa054
    UR  - https://doi.org/10.1093/ckj/sfaa054
    ER  - 
    
  3. Plym A, Johansson AL, Bower H, Wennstig AK, Fredriksson I, Ahlgren J, et al. Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study. Breast Cancer Research and Treatment 2020;182:699-707. View →
    Cite
    @article{plym2020,
      author  = {Plym, A. and Johansson, A. L. and Bower, H. and Wennstig, A. K. and Fredriksson, I. and Ahlgren, J. and others},
      title   = {{Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study}},
      journal = {Breast Cancer Research and Treatment},
      year    = {2020},
      volume  = {182},
      pages   = {699--707},
      doi     = {10.1007/s10549-020-05720-4}
    }
    
    TY  - JOUR
    AU  - Plym, A.
    AU  - Johansson, A. L.
    AU  - Bower, H.
    AU  - Wennstig, A. K.
    AU  - Fredriksson, I.
    AU  - Ahlgren, J.
    TI  - Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study
    JO  - Breast Cancer Research and Treatment
    PY  - 2020
    VL  - 182
    SP  - 699
    EP  - 707
    DO  - 10.1007/s10549-020-05720-4
    UR  - https://doi.org/10.1007/s10549-020-05720-4
    ER  - 
    

2019

  1. Bower H, Crowther MJ, Rutherford MJ, Andersson TML, Clements M, Liu X, Dickman PW, Lambert PC. Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study. Communications in Statistics – Simulation and Computation 2019;50(11):3777-3793. View →
    Cite
    @article{bower2019,
      author  = {Bower, H. and Crowther, M. J. and Rutherford, M. J. and Andersson, T. M. L. and Clements, M. and Liu, X. and Dickman, P. W. and Lambert, P. C.},
      title   = {{Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study}},
      journal = {Communications in Statistics -- Simulation and Computation},
      year    = {2019},
      volume  = {50},
      number  = {11},
      pages   = {3777--3793},
      doi     = {10.1080/03610918.2019.1634201}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Crowther, M. J.
    AU  - Rutherford, M. J.
    AU  - Andersson, T. M. L.
    AU  - Clements, M.
    AU  - Liu, X.
    AU  - Dickman, P. W.
    AU  - Lambert, P. C.
    TI  - Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study
    JO  - Communications in Statistics – Simulation and Computation
    PY  - 2019
    VL  - 50
    IS  - 11
    SP  - 3777
    EP  - 3793
    DO  - 10.1080/03610918.2019.1634201
    UR  - https://doi.org/10.1080/03610918.2019.1634201
    ER  - 
    
  2. Plym A, Johansson AL, Bower H, Voss M, Holmberg L, Fredriksson I, et al. Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age. The Breast 2019;45:48-55. View →
    Cite
    @article{plym2019,
      author  = {Plym, A. and Johansson, A. L. and Bower, H. and Voss, M. and Holmberg, L. and Fredriksson, I. and others},
      title   = {{Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age}},
      journal = {The Breast},
      year    = {2019},
      volume  = {45},
      pages   = {48--55},
      doi     = {10.1016/j.breast.2019.02.012}
    }
    
    TY  - JOUR
    AU  - Plym, A.
    AU  - Johansson, A. L.
    AU  - Bower, H.
    AU  - Voss, M.
    AU  - Holmberg, L.
    AU  - Fredriksson, I.
    TI  - Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age
    JO  - The Breast
    PY  - 2019
    VL  - 45
    SP  - 48
    EP  - 55
    DO  - 10.1016/j.breast.2019.02.012
    UR  - https://doi.org/10.1016/j.breast.2019.02.012
    ER  - 
    
  3. Bower H, Andersson TM, Syriopoulou E, Rutherford MJ, Lambe M, Ahlgren J, et al. Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated–Three what-if scenarios. The Breast 2019;45:75-81. View →
    Cite
    @article{bower2019b,
      author  = {Bower, H. and Andersson, T. M. and Syriopoulou, E. and Rutherford, M. J. and Lambe, M. and Ahlgren, J. and others},
      title   = {{Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated--Three what-if scenarios}},
      journal = {The Breast},
      year    = {2019},
      volume  = {45},
      pages   = {75--81},
      doi     = {10.1016/j.breast.2019.03.005}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Andersson, T. M.
    AU  - Syriopoulou, E.
    AU  - Rutherford, M. J.
    AU  - Lambe, M.
    AU  - Ahlgren, J.
    TI  - Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated–Three what-if scenarios
    JO  - The Breast
    PY  - 2019
    VL  - 45
    SP  - 75
    EP  - 81
    DO  - 10.1016/j.breast.2019.03.005
    UR  - https://doi.org/10.1016/j.breast.2019.03.005
    ER  - 
    

2018

  1. Landtblom AR, Bower H, Andersson TML, Dickman PW, Samuelsson J, Björkholm M, et al. Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia 2018;32(10):2203-10. View →
    Cite
    @article{landtblom2018,
      author  = {Landtblom, A. R. and Bower, H. and Andersson, T. M. L. and Dickman, P. W. and Samuelsson, J. and Björkholm, M. and others},
      title   = {{Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients}},
      journal = {Leukemia},
      year    = {2018},
      volume  = {32},
      number  = {10},
      pages   = {2203--10},
      doi     = {10.1038/s41375-018-0027-y}
    }
    
    TY  - JOUR
    AU  - Landtblom, A. R.
    AU  - Bower, H.
    AU  - Andersson, T. M. L.
    AU  - Dickman, P. W.
    AU  - Samuelsson, J.
    AU  - Björkholm, M.
    TI  - Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
    JO  - Leukemia
    PY  - 2018
    VL  - 32
    IS  - 10
    SP  - 2203
    EP  - 10
    DO  - 10.1038/s41375-018-0027-y
    UR  - https://doi.org/10.1038/s41375-018-0027-y
    ER  - 
    
  2. Bower H, Andersson TML, Crowther MJ, Dickman PW, Lambe M, Lambert PC. Adjusting expected mortality rates using information from a control population: an example using socioeconomic status. American Journal of Epidemiology 2018;187(4):828-36. View →
    Cite
    @article{bower2018,
      author  = {Bower, H. and Andersson, T. M. L. and Crowther, M. J. and Dickman, P. W. and Lambe, M. and Lambert, P. C.},
      title   = {{Adjusting expected mortality rates using information from a control population: an example using socioeconomic status}},
      journal = {American Journal of Epidemiology},
      year    = {2018},
      volume  = {187},
      number  = {4},
      pages   = {828--36},
      doi     = {10.1093/aje/kwx303}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Andersson, T. M. L.
    AU  - Crowther, M. J.
    AU  - Dickman, P. W.
    AU  - Lambe, M.
    AU  - Lambert, P. C.
    TI  - Adjusting expected mortality rates using information from a control population: an example using socioeconomic status
    JO  - American Journal of Epidemiology
    PY  - 2018
    VL  - 187
    IS  - 4
    SP  - 828
    EP  - 36
    DO  - 10.1093/aje/kwx303
    UR  - https://doi.org/10.1093/aje/kwx303
    ER  - 
    
  3. Plym A, Bower H, Fredriksson I, Holmberg L, Lambert PC, Lambe M. Loss in working years after a breast cancer diagnosis. British Journal of Cancer 2018;118(5):738-43. View →
    Cite
    @article{plym2018,
      author  = {Plym, A. and Bower, H. and Fredriksson, I. and Holmberg, L. and Lambert, P. C. and Lambe, M.},
      title   = {{Loss in working years after a breast cancer diagnosis}},
      journal = {British Journal of Cancer},
      year    = {2018},
      volume  = {118},
      number  = {5},
      pages   = {738--43},
      doi     = {10.1038/bjc.2017.456}
    }
    
    TY  - JOUR
    AU  - Plym, A.
    AU  - Bower, H.
    AU  - Fredriksson, I.
    AU  - Holmberg, L.
    AU  - Lambert, P. C.
    AU  - Lambe, M.
    TI  - Loss in working years after a breast cancer diagnosis
    JO  - British Journal of Cancer
    PY  - 2018
    VL  - 118
    IS  - 5
    SP  - 738
    EP  - 43
    DO  - 10.1038/bjc.2017.456
    UR  - https://doi.org/10.1038/bjc.2017.456
    ER  - 
    

2017

  1. Syriopoulou E, Bower H, Andersson TM, Lambert PC, Rutherford MJ. Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England. British Journal of Cancer 2017;117(9):1419-26. View →
    Cite
    @article{syriopoulou2017,
      author  = {Syriopoulou, E. and Bower, H. and Andersson, T. M. and Lambert, P. C. and Rutherford, M. J.},
      title   = {{Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England}},
      journal = {British Journal of Cancer},
      year    = {2017},
      volume  = {117},
      number  = {9},
      pages   = {1419--26},
      doi     = {10.1038/bjc.2017.300}
    }
    
    TY  - JOUR
    AU  - Syriopoulou, E.
    AU  - Bower, H.
    AU  - Andersson, T. M.
    AU  - Lambert, P. C.
    AU  - Rutherford, M. J.
    TI  - Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England
    JO  - British Journal of Cancer
    PY  - 2017
    VL  - 117
    IS  - 9
    SP  - 1419
    EP  - 26
    DO  - 10.1038/bjc.2017.300
    UR  - https://doi.org/10.1038/bjc.2017.300
    ER  - 
    
  2. Marlow N, Bower H, Jones D, Brocklehurst P, Kenyon S, Pike K, Taylor D, Salt A. The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav. Archives of Disease in Childhood - Fetal and Neonatal Edition 2017;102(2):F131-F135. View →
    Cite
    @article{marlow2017,
      author  = {Marlow, N. and Bower, H. and Jones, D. and Brocklehurst, P. and Kenyon, S. and Pike, K. and Taylor, D. and Salt, A.},
      title   = {{The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav}},
      journal = {Archives of Disease in Childhood - Fetal and Neonatal Edition},
      year    = {2017},
      volume  = {102},
      number  = {2},
      pages   = {F131--F135},
      doi     = {10.1136/archdischild-2015-310144}
    }
    
    TY  - JOUR
    AU  - Marlow, N.
    AU  - Bower, H.
    AU  - Jones, D.
    AU  - Brocklehurst, P.
    AU  - Kenyon, S.
    AU  - Pike, K.
    AU  - Taylor, D.
    AU  - Salt, A.
    TI  - The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav
    JO  - Archives of Disease in Childhood - Fetal and Neonatal Edition
    PY  - 2017
    VL  - 102
    IS  - 2
    SP  - F131-F135
    DO  - 10.1136/archdischild-2015-310144
    UR  - https://doi.org/10.1136/archdischild-2015-310144
    ER  - 
    

2016

  1. Bower H, Crowther MJ, Lambert PC. strcs: A command for fitting flexible parametric survival models on the log-hazard scale. The Stata Journal 2016;16(4):989-1012. View →
    Cite
    @article{bower2016,
      author  = {Bower, H. and Crowther, M. J. and Lambert, P. C.},
      title   = {{strcs: A command for fitting flexible parametric survival models on the log-hazard scale}},
      journal = {The Stata Journal},
      year    = {2016},
      volume  = {16},
      number  = {4},
      pages   = {989--1012},
      doi     = {10.1177/1536867x1601600410}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Crowther, M. J.
    AU  - Lambert, P. C.
    TI  - strcs: A command for fitting flexible parametric survival models on the log-hazard scale
    JO  - The Stata Journal
    PY  - 2016
    VL  - 16
    IS  - 4
    SP  - 989
    EP  - 1012
    DO  - 10.1177/1536867x1601600410
    UR  - https://doi.org/10.1177/1536867x1601600410
    ER  - 
    
  2. Bower H, Björkholm M, Dickman PW, Höglund M, Lambert PC, Andersson TML. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. Journal of Clinical Oncology 2016;34(24):2851-7. View →
    Cite
    @article{bower2016b,
      author  = {Bower, H. and Björkholm, M. and Dickman, P. W. and Höglund, M. and Lambert, P. C. and Andersson, T. M. L.},
      title   = {{Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population}},
      journal = {Journal of Clinical Oncology},
      year    = {2016},
      volume  = {34},
      number  = {24},
      pages   = {2851--7},
      doi     = {10.1200/jco.2015.66.2866}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Björkholm, M.
    AU  - Dickman, P. W.
    AU  - Höglund, M.
    AU  - Lambert, P. C.
    AU  - Andersson, T. M. L.
    TI  - Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population
    JO  - Journal of Clinical Oncology
    PY  - 2016
    VL  - 34
    IS  - 24
    SP  - 2851
    EP  - 7
    DO  - 10.1200/jco.2015.66.2866
    UR  - https://doi.org/10.1200/jco.2015.66.2866
    ER  - 
    
  3. Bower H, Andersson TM, Björkholm M, Dickman P, Lambert PC, Derolf ÅR. Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood cancer journal 2016;6(2):e390-0. View →
    Cite
    @article{bower2016c,
      author  = {Bower, H. and Andersson, T. M. and Björkholm, M. and Dickman, P. and Lambert, P. C. and {Derolf ÅR}},
      title   = {{Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life}},
      journal = {Blood cancer journal},
      year    = {2016},
      volume  = {6},
      number  = {2},
      pages   = {e390--0},
      doi     = {10.1038/bcj.2016.3}
    }
    
    TY  - JOUR
    AU  - Bower, H.
    AU  - Andersson, T. M.
    AU  - Björkholm, M.
    AU  - Dickman, P.
    AU  - Lambert, P. C.
    AU  - Derolf ÅR
    TI  - Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life
    JO  - Blood cancer journal
    PY  - 2016
    VL  - 6
    IS  - 2
    SP  - e390-0
    DO  - 10.1038/bcj.2016.3
    UR  - https://doi.org/10.1038/bcj.2016.3
    ER  - 
    

Work with Hannah and the team

Tell us about your project, submission, or training need and we'll connect you with the right expert.

Get in touch Start a project